NCT02688803 2025-12-04OTT15-04Ottawa Hospital Research InstitutePhase 4 Terminated2 enrolled 4 charts
NCT04031885 2021-08-24A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast CancerEli Lilly and CompanyPhase 4 Terminated4 enrolled 9 charts